Replies to post #13115 on Momenta Pharmaceuticals, Inc. (MNTA)

[indigokid]

Yes. A little under the radar and a good generic to go after since everyone else is focusing on the big biologics.

[semi_infinite]

Do you see any technical barrier to entry from other FoB players? Seems that wherever there is money to be made (or the mirage of it), competition develops within months. Just as with Lovenox and probably Copaxone. They need multiple FoBs to have a viable business and it looks like that's what they are doing.

[jbog]

There are a few small guys working on Orencia so momenta's certainly not alone.